Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on USP28 Inhibitors. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114805367A discloses novel triazolopyrimidine derivatives with potent USP28 inhibitory activity, offering a scalable route for high-purity pharmaceutical intermediate manufacturing.